Clovis Oncology reported $230.2M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Acorda Therapeutics ACOR:US $ 45.71M 71.06M
Agenus AGEN:US $ 73.54M 45.82M
Agios Pharmaceuticals AGIO:US $ 969.12M 918.9M
Anika Therapeutics ANIK:US $ 97.18M 2.58M
Arrowhead Research ARWR:US $ 325.98M 46.4M
Astrazeneca AZN:US $ 15567M 7931M
AstraZeneca AZN:LN 15567M 7931M
Cerulean Pharma CERU:US $ 9.11M 1.45M
Clovis Oncology CLVS:US $ 230.2M 39.28M
Eli Lilly And LLY:US $ 3220M 217.6M
Enanta Pharmaceuticals ENTA:US $ 4.6M 72.53M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
GlaxoSmithKline GSK:LN 3503M 1254M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Halozyme Therapeutics HALO:US $ 446.97M 52.48M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Insmed INSM:US $ 928.33M 518.58M
Intrexon XON:US $ 36.41M 9.06M
Ligand Pharmaceuticals LGND:US $ 301.83M 269.98M
Mirati Therapeutics MRTX:US $ 258.99M 35.9M
Neurocrine Biosciences NBIX:US $ 368M 15.4M
Novartis NOVN:VX SF 5117M 1316M
Puma Biotechnology PBYI:US $ 89.85M 5.8M
Rigel Pharmaceuticals RIGL:US $ 84.82M 64.78M
Sangamo Biosciences SGMO:US $ 169.88M 46.9M
Seattle Genetics SGEN:US $ 413.43M 39.72M
Ultragenyx Pharmaceutical RARE:US $ 290.88M 92.92M
Veracyte VCYT:US $ 327.54M 3.48M
YTE INCY:US $ 1797.58M 127.61M